demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID 19 hospitalizedCOVID-19 mild to moderateCOVID-19 severe or critically
lopinavir/ritonavir SOLIDARITY ... Nojomi Ader ... RECOVERY ELACOI ... REMAP-CAP ... Cao

3 studies excluded by filtering options 0

5210 Ye et al., 2020 2990excludednot a RCTrisk of bias not avaialble
5611 Wang, 0 0130selection pending
6751 Chen_lopi_rito, 2020 1134not a RCThigh risk of bias